A Single Dose Study to Evaluate the Pharmacokinetics of LY3209590 in Pediatric Participants with Type 2 Diabetes Mellitus Protocol Number: I8H-MC-BDDB

Go Back to All Clinical Trials

A Single Dose Study to Evaluate the Pharmacokinetics of LY3209590 in Pediatric Participants with Type 2 Diabetes Mellitus Protocol Number: I8H-MC-BDDB

Brief description of study

The purpose of this research study is find out about the safety and tolerability of an experimental drug (LY3209590) for the treatment of pediatric type 2 diabetes mellitus (T2DM) which is a once weekly treatment option.

This study will last about 100 days and will involve about 8 visits. Participants will be administered a single dose of a study drug as an injection their belly. Participants will be asked to monitor their glucose levels using a glucose meter provided by the study team.

Clinical Study Identifier: s24-00331

ClinicalTrials.gov Identifier: NCT06362265

Principal Investigator: Mary Patricia Gallagher.

Other Investigator: Emily Breidbart.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies